You are here

Takeda

Takeda bids adieu to Uloric after gout med's gradual fade from glory

Fierce Pharma

Sun, 01/26/25 - 04:14 pm

BMS, Takeda's Chinese partners file for IPOs, sending Ascentage, Biokin and Bao bundling toward listings

Fierce Biotech

Wed, 01/22/25 - 07:28 pm

Bristol Myers Squibb

Ascentage Pharma

Sichuan Biokin Pharmaceutical

Takeda backs biomarker trial for Crohn's prevention

Pharmaphorum

Wed, 01/22/25 - 11:18 am

Crohn's Disease

JPM25: Takeda spotlights 6 pipeline assets that could pull down up to $20B in collective peak sales

Fierce Pharma

Wed, 01/15/25 - 11:52 pm

Takeda pays Keros $200M upfront for rival to BMS' booming blockbuster Reblozyl

Fierce Biotech

Tue, 12/3/24 - 11:00 am

Keros Therapeutics

Bristol Myers Squibb

GSK calls it quits on trade group BIO for 2025, following exits by Takeda, UCB and more

Fierce Pharma

Sun, 11/10/24 - 09:33 pm

Japan's Takeda raises full-year profit forecast amid restructuring

MSN/Reuters

Thu, 10/31/24 - 10:47 pm

Takeda details another round of layoffs in Massachusetts as restructuring drive rolls on

Fierce Pharma

Mon, 10/21/24 - 11:34 am

Goodbye Wave: Takeda axes Huntington’s pact, freeing partner to pursue fresh pact

Fierce Biotech

Wed, 10/16/24 - 09:54 am

Wave Life Sciences

Huntington's disease

After epilepsy setback, Ovid charges confidently ahead in CNS

Pharma Voice

Fri, 09/20/24 - 10:27 am

Ovid Therapeutics

US allows increased production of Takeda's ADHD drug to address shortage

Reuters

Wed, 09/4/24 - 11:35 am

With a new oncology head, Takeda revamps its R&D strategy

Pharma Voice

Tue, 08/27/24 - 10:54 am

Lundbeck leaves Trintellix to partner Takeda in the US, opting for royalties as it focuses efforts on Rexulti

Fierce Pharma

Wed, 07/31/24 - 11:16 pm

antidepressants

Takeda takes $140M charge on failed epilepsy drug, while touting continued FDA potential

Fierce Biotech

Wed, 07/31/24 - 10:53 am

Takeda spinout HilleVax sees stock sink 80% as norovirus vaccine flunks phase 2 trial in infants

Fierce Biotech

Tue, 07/9/24 - 11:21 am

clinical trials

Lilly inks $3.2B Morphic buyout to snag oral rival to Takeda's IBD blockbuster

Fierce Biotech

Mon, 07/8/24 - 11:54 am

Takeda to cut another 220 jobs in Massachusetts, while Merck KGaA plots its own layoffs

Fierce Pharma

Tue, 07/2/24 - 11:12 am

Takeda reports positive data from Phase IIb trial of ITP treatment

Clinical Trials Arena

Mon, 06/24/24 - 11:18 am

clinical trials. dengvaxia

Takeda gives Sun Pharma, Cipla rights to commercialize gastro drug in India

Reuters

Fri, 06/21/24 - 11:02 am

Takeda flunks pivotal epilepsy tests but mulls path to market for Ovid-partnered prospect

Fierce Biotech

Mon, 06/17/24 - 11:29 am

clinical trials

Ovid Therapeutics

Dravet syndrome

Pages